AMPD3 and type 2 diabetes mellitus: Taken together with the changes in BCAA metabolic pathway observed in OLETF hearts (Figure 1f), the results suggest that the downregulation of BCKDH expression is upstream of AMPD3 upregulation, which further suppresses BCKDH activity in T2DM hearts.